This product is intended strictly for laboratory research and analytical purposes only.
These products are not intended for human or animal consumption, nor for use in clinical or therapeutic applications. While some specific peptide-based medications have received FDA approval for medical use, the research-grade products provided here have not been evaluated, tested, or approved by the FDA or any other regulatory authority for safety, efficacy, or suitability for human or animal use.
Product name: CJC-1295 (no DAC)
Physical form: Lyophilised powder
Purity: 99%
Molecular Type: Synthetic Growth Hormone-Releasing Hormone (GHRH) Analog
Chain length: 29 amino acids
Molecular formula: C₁₆₅ H₂₆₉ N₄₇ O₄₆
Molecular weight: -3367.2 g/mol
Primary identifier: CAS# 863288-34-0
CJC-1295 (no DAC) is a synthetic analog of the growth hormone-releasing hormone (GHRH) consisting of the first 29 amino acids of the native peptide, specifically modified to enhance its resistance to enzymatic degradation while maintaining its ability to stimulate growth hormone secretion. In research, this peptide is frequently studied for its potential to increase natural growth hormone and IGF-1 levels, which may support improvements in body composition, lean muscle mass, and recovery rates, as well as potential benefits for sleep quality and skin elasticity.
This product is intended strictly for laboratory research and analytical purposes only.
CoA available
